Arthur P. Bollon
Chief Executive Officer at Vitruvian BioMedical, Inc.
Profile
Arthur P.
Bollon was the founder of Biogress LLC (founded in 2003), Wadley Biosciences, Inc. (founded in 1987), Cytoclonal Pharmaceutics, Inc. (founded in 1992), and Vitruvian BioMedical, Inc. (founded in 2011) where he held the titles of Chairman & Chief Executive Officer.
He is currently an Independent Director at SignPath Pharma, Inc. (since 2008).
Dr. Bollon's former positions include President & Chief Executive Officer at Hemobiotech, Inc. (2003-2010) and Director at Immunotech Laboratories, Inc. He holds a doctorate degree from The Waksman Institute of Microbiology.
Arthur P. Bollon active positions
| Companies | Position | Start |
|---|---|---|
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Director/Board Member | 27/05/2008 |
Vitruvian BioMedical, Inc.
 Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Chief Executive Officer | 31/12/2010 |
Former positions of Arthur P. Bollon
| Companies | Position | End |
|---|---|---|
Hemobiotech, Inc.
 Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Chief Executive Officer | 31/07/2010 |
| Cytoclonal Pharmaceutics, Inc. | Chief Executive Officer | 31/12/1999 |
| Wadley Biosciences, Inc. | Chief Executive Officer | 31/12/1990 |
| IMMUNOTECH LABORATORIES, INC. | Director/Board Member | - |
| Biogress LLC | Founder | - |
Training of Arthur P. Bollon
| The Waksman Institute of Microbiology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNOTECH LABORATORIES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Hemobiotech, Inc.
Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
| Biogress LLC | |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |
| Cytoclonal Pharmaceutics, Inc. | Health Technology |
| Wadley Biosciences, Inc. | |
Vitruvian BioMedical, Inc.
Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Commercial Services |
- Stock Market
- Insiders
- Arthur P. Bollon
